research 0245 Topical minoxidil toxicosis in cats and dogs
Topical minoxidil is dangerous for cats and dogs.
Search
forResearch
5 / 1000+ resultsresearch Topical Minoxidil Exposures and Toxicoses in Dogs and Cats: 211 Cases (2001–2019)
This study observed that accidental topical minoxidil exposure can cause toxicosis in dogs and cats, leading to moderate or major illness, and even death in some cats.
research Minoxidil toxicosis in cats and dogs: A scoping review and call to action
This scoping review investigates cases of toxic minoxidil exposure in cats and dogs, detailing their clinical presentations, management strategies, and outcomes, without reporting specific results.
research Successful management of suspected minoxidil toxicosis in a cat following accidental dermal exposure
This report presents the first successful management of minoxidil toxicosis in a cat, detailing the clinical progression and treatment plan used to resolve the condition.
research Presumptive Albendazole Toxicosis in 12 Alpacas
This study describes presumed albendazole toxicosis in alpacas, suggesting that repeated doses as low as 19 mg/kg can lead to severe neutropenia, enteropathy, and potentially death in this species.
Community Join
5 / 1000+ resultscommunity if you use minoxidil and have a pet, read this
Minoxidil is toxic to pets, with a 15% mortality rate in cats, often due to indirect exposure like contact with pillows or hands. Users suggest using common sense, such as keeping pets away from treated areas, using foam that dries quickly, and washing hands after application to prevent harm.
community Topical minoxidil can still kill cats even when the owner is “careful.”
Topical minoxidil can be dangerous to cats, even with accidental exposure, and users should be cautious to prevent poisoning. Proper precautions, like washing hands and preventing cats from licking treated areas, are essential to minimize risk.
community Warning: Minoxidil usage around pets
Minoxidil is highly toxic to pets, especially cats and dogs, even in small amounts. Many users have switched to oral minoxidil to prevent accidental exposure to their pets.
community "Clinical efficacy of microneedle combined with 5% Minoxidil solution and finasteride in the treatment of androgenetic alopecia in males"
Microneedling combined with 5% Minoxidil and finasteride significantly improves hair growth compared to using Minoxidil or Minoxidil with finasteride alone. The combination treatment is safe and effective, but further research is needed due to small sample size and short study duration.
community Clinical efficacy of popular oral supplements for AA
Vitamins and minerals like vitamin E, zinc, and iron may aid hair growth, especially in cases of deficiency. Pumpkin seed oil, saw palmetto, horsetail, and AminoMar show some promise for improving hair health and count.
Learn
5 / 801 results- Are there clinical studies showing that KY19382 can regrow hair in androgenic alopecia? No clinical studies have proven KY19382 regrows hair in androgenic alopecia.
- What do clinical trials say about the safety and effectiveness of SCUBE3 for hair regrowth? No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.
- Are there any clinical studies supporting follistatin as a hair loss treatment? There is no controlled human trial showing follistatin treats hair loss; the published work is mouse and laboratory biology on the activin/follistatin signalling system, plus one small 2011 phase 1 injection study of a combination product, so follistatin remains experimental and unapproved.
- What types of hair loss conditions are most commonly associated with tofacitinib use in clinical settings? Published studies link tofacitinib mainly to alopecia areata and its severe variants — as an off-label drug being studied for them, not as a cause of hair loss. The evidence is mostly small, open-label or retrospective, and relapse after stopping is commonly reported.
- When will GT20029 be commercially available, and are there any clinical trials on its use? GT20029 is not approved or commercially available anywhere and remains investigational. A published 12-week Phase II study in 180 Chinese men reports hair-count gains over placebo, but no long-term or Phase III data exists, so any launch is years away at best.
learn KY19382
learn SCUBE3
learn Follistatin
learn Tofacitinib
learn GT20029
Clinics
6 / 500 results- 29
TrichologyHair TransplantCLINICAL HAIR&HEALTHOstrava · CZ - 33
Hair TransplantHair Loss TreatmentsClinical BédardMontréal, QC · CA - 11
Hair Loss TreatmentsClinical Francisco DuarteBelo Horizonte, MG · BR - 35
Hair Loss TreatmentsClinical Hair & beautyCórdoba, CB · AR - 12Hair Loss TreatmentsClinical Aesthetic SolvayLiège · BE
- 25Hair TransplantClinical Aesthetics of TulsaTulsa, OK · US
Experts
— no results